Member Info for Early_Bird

That is one cracking read! "I was lucky to have been brought into Ophir where we grew the business from $10m to $3.2bn. I have contacts in the majority of large companies and if we do something interesting then I am pretty sure we could bring in a partner"" NT NT NT NT to buy.. wake up mms

Fundamentals here are now much better than when GEO had huge backing at 16p.. now 10p to buy. Martin Struthers (Lundin) has replaced Greg Kuenzel as CEO of GEO I see an easy 150% here over the next few months

Secured a farm in for 3 wells fully carried. Great stuff.

Mr Struthers replaces Greg K as CEO! Cracking RNS.

https://goo.gl/3NESru I also see this as a cracking buy op down here at �5m mcap and now funded. Come the June/July spud of Biscathorpe id expect �10-12m mcap minimum given 3mmbol net (best case) and up to 8mmbol net at 40% COS and thats ignoring any other assets that UJO have. Big interest will build being on shore UK. Any positive update from Wressle and this is really going to take off (wildcard bonus). DB is about as trustworthy a CEO as you can get on AIM, he is no frills but also no BS. I trust the guy to move this forward. I was involved in the 0.85p placing but have since double up my holding on the open market at 0.9p.

I see a bargain down here given huge ii backing at 16p last year. Only change is timescales. Same shit management as back then and it still got backing. The asset is shaping up to be world class. JV now paying half of all costs going forward... Production this year and back to 25p highs. Downside is limited here. All IMO.

As I confirmed with you Fundraiser222 I have had my broker look in to who is selling, Northland have been looking and there is no large seller. Just placees for December likely using the recent volume. Price is all time lows, Just like a drill catalyst those Phase 2 readouts are looming close now. In previous years (15, 16 & 17) EVG never had this big catalyst, hence why I see now as the big inflexion point in the SP. Closer we get to end of June the more the heat turns up. EVG is funded to completion of phase 2 trials, so really a great R v R investment down here. Lots have been turbo trading this chaging their tune on their position which is clear as day to see. Those that believe in the company and have invested on the fundamentals will reap the benfits.

lumpy buying continues. On the risers board :-)

Good sign. All those loose shares getting mopped up in to sticky hands. We are back on all time lows here, the last time I suggested this were a buy at 8p it went to 24p in the 6 months following.... If BOD deliver the production (remains to be seen but their work plan now at least sets out the conditions) then I see 24p back on the cards in the next 6 months. Key for me here is they still have solid cash.

Significant holder increasing their holding further https://uk.advfn.com/stock-market/london/GEO/share-news/Georgian-Mining-Corporation-TR-1-Notification-of/77017462?adw=1126416

Link: https://goo.gl/oiyRJ1

25mins in: https://www.**********.co.uk/blogs/ferrum-cresent-fcr-botswana-diamonds-bod-john-meyer-geo-vanadium/

Steve Franklin, CEO of Evgen Pharma, said: ''We welcome the opportunity to work with Professor Tate whose innovations in the field of chemical proteomics provide the opportunity to improve our knowledge of SFX-01's mechanism of action in cancer and neurology. Meanwhile, we look forward to our first Phase II clinical data from SFX-01 in breast cancer in the first half of this year, when we will announce the interim readout from our ongoing STEM trial."

Taken from the fincapp note. "Success in the Mengo (increase to 750bopd) rated at a 50% chance of success, �69m valuation. Success in the Djeno (10000 bopd) rated a 25% chance of success, �760m valuation". VS MC �10m. $4.1m cash @ End of Sept. Drilling June spud date and rig booked. And still people are worried about the possible equity required of �2m-3m which may or may not even be through a placing. TLP103 is 50% chance of of �69m + 25% chance of �760m Then the workovers of 101 and 102 are an added bonus. Remember "At $50 oil, the management estimate 180bopd would see them reach cash flow breakeven." Baring in mind the current oil price is at $65 oil you are looking at a net profit on the bottom line if these achieve 180boepd combined.

H1 catalyst isnt that far off and I also think there will be news incoming on grant funding to explore some sulforaphrane analogues. No doubt big pharma will be watching here with a very keen eye.

whatever was selling has now stopped. �12m mcap.. fully funded through 2018 for completion of its phase 2 trial data readouts. First being H1 (interim). IPO MC �27mcap 2 1/2 years ago & all positive news has landed since, and now in sharp end of delivery. Just dont see the downside here.

Frankly amazed its still trading down here.

People need to research this asset... the key here to unlocking an ARS style re-rate IMO. Company have been tweeting cryptic clues. looking forward to the next few updates

Agree 100% with that. Solid cash atm here and JV now paying half. Locking these up with a 3-6 month view. Expect this will be back over 16p by June as drilling results, feasibility, production etc are all due around then. Interesting SP article thinks we will be getting an update on cashflows shortly.

different beast now with JB running the show. The last piece of the jugsaw to me will be the most satisfying here as its all about supply v demand. Every man and their dog want in on the last jigsaw piece being put in to place, I wonder if their plans will be scuppered. Anyway glad im loaded and have extreme confidence now in the board.